Trial intelligence / Profile preview

AMT-143 for Postsurgical Analgesia After Unilateral Bunionectomy

NCT07858734Phase 2Not yet recruiting

Sponsor
AmacaThera
Start
Dec 2026
Primary completion
Apr 2027
01

Overview

A Phase 2 trial of AMT-143 in Persistent postsurgical pain (PPSP), sponsored by AmacaThera. Planned start Dec 2026; status: not yet recruiting.

02

Drugs

AMT-143
03

Conditions

Persistent postsurgical pain (PPSP)

Beyond the preview

Go deeper on NCT07858734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07858734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call